The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Peptide Health Products Market Research Report 2024

Global Peptide Health Products Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1763588

No of Pages : 104

Synopsis
Global Peptide Health Products market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Peptide Health Products market research.

With the improvement of the quality of life, people pay more and more attention to health care. As a supplementary health care product, health care products have attracted more and more attention. Among the types of health products, health products containing peptides are highly sought after. Peptide-containing health products include collagen, protein powder, ganoderma peptide, etc.

Generally speaking, there are many types of health products, but the health products containing peptides are very effective. Peptides can enhance the body's immunity, promote the metabolism of skin cells, strengthen muscles, etc., and play a very important role in maintaining health.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Peptide Health Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Amway
  • Suntory
  • GNC
  • Infinitus
  • Herbalife Nutrition
  • USANA Health Sciences, Inc.
  • Perfect (China) Co., Ltd.
  • Nestlé SA
  • H&H Group
  • China New Era Group Corporation
  • By-health
  • Black Mores
  • Glanbia Plc
  • Nature’s
  • Real Nutriceutical
  • China Beijing Tong Ren Tang Group
  • Xiamen Kingdomway

Segment by Type

  • Collagen
  • Protein Powder
  • Ganoderma Peptide
  • Others

Segment by Application

  • Tablet
  • Capsule
  • Oral Liquid
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Peptide Health Products report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Health Products Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Collagen
1.2.3 Protein Powder
1.2.4 Ganoderma Peptide
1.2.5 Others
1.3 Market by Application
1.3.1 Global Peptide Health Products Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Oral Liquid
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Health Products Market Perspective (2018-2029)
2.2 Peptide Health Products Growth Trends by Region
2.2.1 Global Peptide Health Products Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Peptide Health Products Historic Market Size by Region (2018-2023)
2.2.3 Peptide Health Products Forecasted Market Size by Region (2024-2029)
2.3 Peptide Health Products Market Dynamics
2.3.1 Peptide Health Products Industry Trends
2.3.2 Peptide Health Products Market Drivers
2.3.3 Peptide Health Products Market Challenges
2.3.4 Peptide Health Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Health Products Players by Revenue
3.1.1 Global Top Peptide Health Products Players by Revenue (2018-2023)
3.1.2 Global Peptide Health Products Revenue Market Share by Players (2018-2023)
3.2 Global Peptide Health Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Health Products Revenue
3.4 Global Peptide Health Products Market Concentration Ratio
3.4.1 Global Peptide Health Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Health Products Revenue in 2022
3.5 Peptide Health Products Key Players Head office and Area Served
3.6 Key Players Peptide Health Products Product Solution and Service
3.7 Date of Enter into Peptide Health Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Health Products Breakdown Data by Type
4.1 Global Peptide Health Products Historic Market Size by Type (2018-2023)
4.2 Global Peptide Health Products Forecasted Market Size by Type (2024-2029)
5 Peptide Health Products Breakdown Data by Application
5.1 Global Peptide Health Products Historic Market Size by Application (2018-2023)
5.2 Global Peptide Health Products Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Peptide Health Products Market Size (2018-2029)
6.2 North America Peptide Health Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Peptide Health Products Market Size by Country (2018-2023)
6.4 North America Peptide Health Products Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Health Products Market Size (2018-2029)
7.2 Europe Peptide Health Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Peptide Health Products Market Size by Country (2018-2023)
7.4 Europe Peptide Health Products Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Health Products Market Size (2018-2029)
8.2 Asia-Pacific Peptide Health Products Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Peptide Health Products Market Size by Region (2018-2023)
8.4 Asia-Pacific Peptide Health Products Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Health Products Market Size (2018-2029)
9.2 Latin America Peptide Health Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Peptide Health Products Market Size by Country (2018-2023)
9.4 Latin America Peptide Health Products Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Health Products Market Size (2018-2029)
10.2 Middle East & Africa Peptide Health Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Peptide Health Products Market Size by Country (2018-2023)
10.4 Middle East & Africa Peptide Health Products Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amway
11.1.1 Amway Company Detail
11.1.2 Amway Business Overview
11.1.3 Amway Peptide Health Products Introduction
11.1.4 Amway Revenue in Peptide Health Products Business (2018-2023)
11.1.5 Amway Recent Development
11.2 Suntory
11.2.1 Suntory Company Detail
11.2.2 Suntory Business Overview
11.2.3 Suntory Peptide Health Products Introduction
11.2.4 Suntory Revenue in Peptide Health Products Business (2018-2023)
11.2.5 Suntory Recent Development
11.3 GNC
11.3.1 GNC Company Detail
11.3.2 GNC Business Overview
11.3.3 GNC Peptide Health Products Introduction
11.3.4 GNC Revenue in Peptide Health Products Business (2018-2023)
11.3.5 GNC Recent Development
11.4 Infinitus
11.4.1 Infinitus Company Detail
11.4.2 Infinitus Business Overview
11.4.3 Infinitus Peptide Health Products Introduction
11.4.4 Infinitus Revenue in Peptide Health Products Business (2018-2023)
11.4.5 Infinitus Recent Development
11.5 Herbalife Nutrition
11.5.1 Herbalife Nutrition Company Detail
11.5.2 Herbalife Nutrition Business Overview
11.5.3 Herbalife Nutrition Peptide Health Products Introduction
11.5.4 Herbalife Nutrition Revenue in Peptide Health Products Business (2018-2023)
11.5.5 Herbalife Nutrition Recent Development
11.6 USANA Health Sciences, Inc.
11.6.1 USANA Health Sciences, Inc. Company Detail
11.6.2 USANA Health Sciences, Inc. Business Overview
11.6.3 USANA Health Sciences, Inc. Peptide Health Products Introduction
11.6.4 USANA Health Sciences, Inc. Revenue in Peptide Health Products Business (2018-2023)
11.6.5 USANA Health Sciences, Inc. Recent Development
11.7 Perfect (China) Co., Ltd.
11.7.1 Perfect (China) Co., Ltd. Company Detail
11.7.2 Perfect (China) Co., Ltd. Business Overview
11.7.3 Perfect (China) Co., Ltd. Peptide Health Products Introduction
11.7.4 Perfect (China) Co., Ltd. Revenue in Peptide Health Products Business (2018-2023)
11.7.5 Perfect (China) Co., Ltd. Recent Development
11.8 Nestlé SA
11.8.1 Nestlé SA Company Detail
11.8.2 Nestlé SA Business Overview
11.8.3 Nestlé SA Peptide Health Products Introduction
11.8.4 Nestlé SA Revenue in Peptide Health Products Business (2018-2023)
11.8.5 Nestlé SA Recent Development
11.9 H&H Group
11.9.1 H&H Group Company Detail
11.9.2 H&H Group Business Overview
11.9.3 H&H Group Peptide Health Products Introduction
11.9.4 H&H Group Revenue in Peptide Health Products Business (2018-2023)
11.9.5 H&H Group Recent Development
11.10 China New Era Group Corporation
11.10.1 China New Era Group Corporation Company Detail
11.10.2 China New Era Group Corporation Business Overview
11.10.3 China New Era Group Corporation Peptide Health Products Introduction
11.10.4 China New Era Group Corporation Revenue in Peptide Health Products Business (2018-2023)
11.10.5 China New Era Group Corporation Recent Development
11.11 By-health
11.11.1 By-health Company Detail
11.11.2 By-health Business Overview
11.11.3 By-health Peptide Health Products Introduction
11.11.4 By-health Revenue in Peptide Health Products Business (2018-2023)
11.11.5 By-health Recent Development
11.12 Black Mores
11.12.1 Black Mores Company Detail
11.12.2 Black Mores Business Overview
11.12.3 Black Mores Peptide Health Products Introduction
11.12.4 Black Mores Revenue in Peptide Health Products Business (2018-2023)
11.12.5 Black Mores Recent Development
11.13 Glanbia Plc
11.13.1 Glanbia Plc Company Detail
11.13.2 Glanbia Plc Business Overview
11.13.3 Glanbia Plc Peptide Health Products Introduction
11.13.4 Glanbia Plc Revenue in Peptide Health Products Business (2018-2023)
11.13.5 Glanbia Plc Recent Development
11.14 Nature’s
11.14.1 Nature’s Company Detail
11.14.2 Nature’s Business Overview
11.14.3 Nature’s Peptide Health Products Introduction
11.14.4 Nature’s Revenue in Peptide Health Products Business (2018-2023)
11.14.5 Nature’s Recent Development
11.15 Real Nutriceutical
11.15.1 Real Nutriceutical Company Detail
11.15.2 Real Nutriceutical Business Overview
11.15.3 Real Nutriceutical Peptide Health Products Introduction
11.15.4 Real Nutriceutical Revenue in Peptide Health Products Business (2018-2023)
11.15.5 Real Nutriceutical Recent Development
11.16 China Beijing Tong Ren Tang Group
11.16.1 China Beijing Tong Ren Tang Group Company Detail
11.16.2 China Beijing Tong Ren Tang Group Business Overview
11.16.3 China Beijing Tong Ren Tang Group Peptide Health Products Introduction
11.16.4 China Beijing Tong Ren Tang Group Revenue in Peptide Health Products Business (2018-2023)
11.16.5 China Beijing Tong Ren Tang Group Recent Development
11.17 Xiamen Kingdomway
11.17.1 Xiamen Kingdomway Company Detail
11.17.2 Xiamen Kingdomway Business Overview
11.17.3 Xiamen Kingdomway Peptide Health Products Introduction
11.17.4 Xiamen Kingdomway Revenue in Peptide Health Products Business (2018-2023)
11.17.5 Xiamen Kingdomway Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’